Our data demonstrate that ATG16L1-deficiency in DCs promotes the development of LP CD8+ TRM cells and increases susceptibility to colitis which can be attenuated by stimulation of the TLR7 signaling pathway. This evidence concerns the gene CD8A and colitis.